Difference between revisions of "rotation:molecualr-april2020week2"

From MGH Learn Pathology
(Created page with "<table class='table border1px' align="center"> <tr> <th width="10%">Time</th> <th width="18%">Monday 4/6</th> <th width="18%">Tuesday 4/7</th> <th width="18%">Wednesday 4/8</t...")
 
Line 2: Line 2:
 
<tr>
 
<tr>
 
<th width="10%">Time</th>
 
<th width="10%">Time</th>
−
<th width="18%">Monday 4/6</th>
+
<th width="18%">Monday 4/13</th>
−
<th width="18%">Tuesday 4/7</th>
+
<th width="18%">Tuesday 4/14</th>
−
<th width="18%">Wednesday 4/8</th>
+
<th width="18%">Wednesday 4/15</th>
−
<th width="18%">Thursday 4/9</th>
+
<th width="18%">Thursday 4/16</th>
−
<th width="18%">Friday 4/10</th>
+
<th width="18%">Friday 4/17</th>
 
</tr>
 
</tr>
 
<tr>
 
<tr>
Line 12: Line 12:
 
<td> </td>
 
<td> </td>
 
<td> </td>
 
<td> </td>
−
<td> </td>
+
<td bgcolor="#7DE3A0" rowspan="3">
−
<td> </td>
+
Alex Farahani
 +
<br>Metabase
 +
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 +
</td>
 +
<td bgcolor="#7DE3A0" rowspan="3">
 +
Alex Farahani
 +
<br>Metabase
 +
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 +
</td>
 
<td> </td>
 
<td> </td>
 
</tr>
 
</tr>
 
<tr>
 
<tr>
 
<th>8:30–9:00</th>
 
<th>8:30–9:00</th>
−
<td bgcolor="#76C9F0" rowspan="2">
+
<td> </td>  
−
CID Consensus
 
−
<br/>Zoom
 
−
</td>
 
 
<td> </td>  
 
<td> </td>  
 
<td> </td>
 
<td> </td>
Line 34: Line 39:
 
<tr>
 
<tr>
 
<th>9:00–9:30</th>
 
<th>9:00–9:30</th>
−
<td bgcolor="#7DE3A0" rowspan="2">
+
<td> </td>
−
Jochen K. Lennerz, M.D., Ph.D.
+
<td> </td>
−
<br>Ensemble
+
<td> </td>
 +
<td> </td>
 +
<td> </td>
 +
</tr>
 +
<tr>
 +
<th>9:30–10:00</th>
 +
<td bgcolor="#76C9F0" rowspan="3">
 +
Valentina Nardi, M.D.
 +
<br>aCGH Case Review
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
 +
<td> </td>
 
<td bgcolor="#76C9F0" rowspan="2">
 
<td bgcolor="#76C9F0" rowspan="2">
−
Team Project Meeting<br>Zoom
+
Dora Dias-Santagata, Ph.D.
−
</td>
+
<br>Thyroid Tumors
−
<td bgcolor="#7DE3A0" rowspan="2">
 
−
Lauren Ritterhouse, M.D., Ph.D.
 
−
<br>NGS Sequencing Technologies
 
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
−
</tr>
+
<td bgcolor="#76C9F0" rowspan="2">
−
<tr>
+
Adam Fisch, M.D., Ph.D.
−
<th>9:30–10:00</th>
+
<br>Fusion Case Review
−
<td bgcolor="#76C9F0" >
 
−
Jochen K. Lennerz, M.D., Ph.D.
 
−
<br>Introduction to CID
 
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
Line 58: Line 66:
 
<tr>
 
<tr>
 
<th>10:00–10:30</th>
 
<th>10:00–10:30</th>
−
<td bgcolor="#76C9F0" rowspan="2">
+
<td bgcolor="#7DE3A0" rowspan="2">
−
Valentina Nardi, M.D.
+
John Iafrate, M.D., Ph.D.
−
<br>Overview/Media Lab/SOPs
+
<br>Liquid Biopsies
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
−
<td bgcolor="#7DE3A0" rowspan="3">
 
−
Valentina Nardi, M.D.
 
−
<br>FISH
 
 
<br>Small Molecular Technologies and Techniques
 
<br>Small Molecular Technologies and Techniques
 
</td>
 
</td>
−
<td bgcolor="#7DE3A0" rowspan="2">
+
</tr>
−
Dora Dias-Santagata, Ph.D.
+
<tr>
−
<br>Chimerism
+
<th>10:30–11:00</th>
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
+
<td> </td>
−
</td>
+
<td bgcolor="#FFB872" rowspan="3">
−
<td bgcolor="#7DE3A0" rowspan="2">
 
 
Jochen K. Lennerz, M.D., Ph.D.
 
Jochen K. Lennerz, M.D., Ph.D.
−
<br>Billing and Reimbursement
+
<br>FISH Case Review
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
−
</tr>
 
−
<tr>
 
−
<th>10:30–11:00</th>
 
 
</tr>
 
</tr>
 
<tr>
 
<tr>
 
<th>11:00–11:30</th>
 
<th>11:00–11:30</th>
−
<td bgcolor="#FFB872" >
+
<td> </td>
−
Jochen K. Lennerz, M.D., Ph.D.
+
<td> </td>
−
<br>Expectations
+
<td bgcolor="#FFB872" rowspan="2">
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
−
<td bgcolor="#7DE3A0" rowspan="2">
 
−
Dora Dias-Santagata, Ph.D.
 
−
<br>aCGH Technique, Cytovision, and Analysis
 
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
−
<td bgcolor="#7DE3A0" rowspan="2">
 
 
Lauren Ritterhouse, M.D., Ph.D.
 
Lauren Ritterhouse, M.D., Ph.D.
−
<br>Tumor Mutational Burden
+
<br>Molecular Oncology of GYN Tumors
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
−
<td bgcolor="#7DE3A0" rowspan="2">
 
−
Valentina Nardi, M.D.
 
−
<br>Interpretation of Gene Fusions
 
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
 +
<td> </td>
 
</tr>
 
</tr>
 
<tr>
 
<tr>
 
<th>11:30–12:00</th>
 
<th>11:30–12:00</th>
−
<td bgcolor="#FFB872" >
+
<td> </td>
−
Adam Fisch, M.D., Ph.D.
+
<td> </td>
−
<br>Pre-Rotation Testing
 
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
 
<td> </td>
 
<td> </td>
 
</tr>
 
</tr>

Revision as of 10:11, April 11, 2020

Time Monday 4/13 Tuesday 4/14 Wednesday 4/15 Thursday 4/16 Friday 4/17
8:00–8:30

Alex Farahani
Metabase
MS Teams Molecular

Alex Farahani
Metabase
MS Teams Molecular

8:30–9:00

Long P. Le, M.D., Ph.D.
Markus Herrmann, M.D., Ph.D.
Computational Pathology
MS Teams Molecular

9:00–9:30
9:30–10:00

Valentina Nardi, M.D.
aCGH Case Review
MS Teams Molecular

Dora Dias-Santagata, Ph.D.
Thyroid Tumors
MS Teams Molecular

Adam Fisch, M.D., Ph.D.
Fusion Case Review
MS Teams Molecular

10:00–10:30

John Iafrate, M.D., Ph.D.
Liquid Biopsies
Small Molecular Technologies and Techniques

10:30–11:00

Jochen K. Lennerz, M.D., Ph.D.
FISH Case Review
MS Teams Molecular

11:00–11:30

Lauren Ritterhouse, M.D., Ph.D.
Molecular Oncology of GYN Tumors
MS Teams Molecular

11:30–12:00
12:00–1:00 OUTS Conference

MS Teams OUTS

OUTS Conference

MS Teams OUTS

OUTS Conference

MS Teams OUTS

AP Lecture Series

MS Teams AP Residents

OUTS Conference

MS Teams OUTS

1:00–1:30

Jochen K. Lennerz, M.D., Ph.D.
Financial Sustainability
MS Teams Molecular

LMM Conference
MS Teams CP Residents

1:30–2:00
2:00–2:30

Valentina Nardi, M.D.
Nomenclature
MS Teams Molecular

Heme Molecular Conference
TBD

Julia Thierauf, M.D.
Clinical Research
MS Teams Molecular

Lauren Ritterhouse, M.D., Ph.D.
Pre-Analytic Factors Affecting Molecular Testing
MS Teams Molecular


Long P. Le, M.D., Ph.D.
Markus Herrmann, M.D., Ph.D.
Computational Pathology
MS Teams Molecular
OR
Research Talks

2:30–3:00
3:00–3:30

Maristela Onozato, M.D., Ph.D.
Research
MS Teams Molecular

Ju Cheng Ph.D.
Translational Research
MS Teams Molecular

Hetal Marble, Ph.D.
CID Core Concept
MS Teams Molecular

3:30–4:00
4:00–4:30

Hetal Marble, Ph.D.
Companion Diagnostics
MS Teams Molecular

4:30–5:00

Molecular residents and HMS students
All: residents, fellows, HMS students
Molecular residents only

Retrieved from "https://learn.mghpathology.org/index.php?title=rotation:molecualr-april2020week2&oldid=32116"
  • Powered by MediaWiki
  • Search Powered by Cargo
  • Massachusetts General Hospital